Prepared For

Ms Sunita Sharma
F 40
fa lse

Name Patient ID Gender Age

Ms Sunita Sharma 10207057 F 40

Health Summary

BLOOD COUNTS

Everything looks good

LIVER PROFILE

Everything looks good

ANEMIA STUDIES

Everything looks good

 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : HQ675130
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 06:24 PM.
Test Description Value(s) Unit(s) Reference Range

Fever Package Advance Plus

Complete Blood Count (CBC)

RBC Parameters
Hemoglobin 13.2 g/dL 13.0 - 17.0
colorimetric
RBC Count 3.9 10^6/µl 3.8 - 4.8
Electrical impedance
PCV 42.5 % 36 - 46
Calculated
MCV 108.1 fl 83 - 101
Calculated
MCH 33.6 pg 27 - 32
Calculated
MCHC 31.1 g/dL 31.5 - 34.5
Calculated
RDW (CV) * 16.3 % 11.6 - 14.0
Calculated
RDW-SD * 63.1 fl 35.1 - 43.9
Calculated
WBC Parameters
TLC 7.3 10^3/µl 4 - 10
Electrical impedance and microscopy
Differential Leucocyte Count
Neutrophils 67.5 % 40-80
Lymphocytes 25.1 % 20-40
Monocytes 3.5 % 2-10
Eosinophils 3.8 % 1-6
Basophils 0.1 % <2
Absolute Leukocyte Counts
Calculated
Neutrophils. 4.93 10^3/µl 2-7
Lymphocytes. 1.83 10^3/µl 1-3
Monocytes. 0.26 10^3/µl 0.2 - 1.0
Eosinophils. 0.28 10^3/µl 0.02 - 0.5
Basophils. 0.01 10^3/µl 0.02 - 0.5
Platelet Parameters
Platelet Count 140 10^3/µl 150 - 410
Electrical impedance and microscopy
Mean Platelet Volume (MPV) * 13.5 fL 9.3 - 12.1
Calculated
PCT * 0.2 % 0.17 - 0.32
Calculated
(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 1 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : HQ675130
Referred BY : Self Sample Type : Whole blood EDTA
Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 06:24 PM.
Test Description Value(s) Unit(s) Reference Range
PDW * 18.4 fL 8.3 - 25.0
Calculated
P-LCR * 52.1 % 18 - 50
Calculated
P-LCC * 63 10^9/L 44 - 140
Calculated
Mentzer Index * 27.72 % > 13
Calculated

Interpretation:
CBC provides information about red cells, white cells and platelets. Results are useful in the diagnosis of anemia, infections, leukemias, clotting
disorders and many other medical conditions.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 2 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : HQ675130
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 08:45 PM.
Test Description Value(s) Unit(s) Reference Range

Erythrocyte Sedimentation Rate (ESR)

ESR - Erythrocyte Sedimentation Rate 11 mm/hr 0 - 12

MODIFIED WESTERGREN

Interpretation:
ESR is also known as Erythrocyte Sedimentation Rate. An ESR test is used to assess inflammation in the body. Many conditions can cause an
abnormal ESR, so an ESR test is typically used with other tests to diagnose and monitor different diseases. An elevated ESR may occur in
inflammatory conditions including infection, rheumatoid arthritis ,systemic vasculitis, anemia, multiple myeloma , etc. Low levels are typically
seen in congestive heart failure, polycythemia ,sickle cell anemia, hypo fibrinogenemia , etc.

Reference- Dacie and lewis practical hematology

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 3 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : HQ675130
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 07:44 PM.
Test Description Value(s) Unit(s) Reference Range

Malarial Parasite (MP) Smear

MP(PBF FOR MP) Not Seen NOT SEEN

MICROSCOPY

Interpretation:
1. Malaria is a serious parasitic diseases characterized by fever, chills, and anemia and is caused by a parasite that is transmitted human to
human by the bite of infected female Anopheles mosquitoes.
2. Malarial Parasite test is performed on the blood sample to find out the level of Malaria Parasite in the blood.
3. It is conducted to conclude on Malaria and also during the treatment and after the treatment of Malaria.
4. Most people will have symptoms within 14 days of being bitten by an infected mosquito. But symptoms can show up as soon as seven days
afterward or can take as long as a year to appear.
5. Clinical decision should not be based on the results of this test, but should be made by the physician after all clinical and laboratory findings
have been evaluated.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 4 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : HQ675130
Referred BY : Self Sample Type : Whole blood EDTA
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 07:44 PM.
Test Description Value(s) Unit(s) Reference Range

Malaria Antigen, Rapid Card

Plasmodium Vivax Negative Negative

Plasmodium falciparum Negative Negative
Interpretation:
Immunochromatographic Assay done for Plasmodium falciparum using Histidine-Rich Protein-II (HRP-II) and Plasmodium species (Plasmodium
falciparum, P. vivax, P. ovale and P. malariae) using lactate dehydrogenase (pLDH) in human whole blood.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 5 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : ZF054025
Referred BY : Self Sample Type : Serum
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 07:08 PM.
Test Description Value(s) Unit(s) Reference Range

Bilirubin (Total, Direct, Indirect)

Bilirubin Total 0.862 mg/dL 0 - 1.2

Colorimetric Diazo
Bilirubin Direct 0.254 mg/dL 0 - 0.5
Bilirubin Indirect 0.61 mg/dL 0.1 - 1.0
Calculation (T Bil - D Bil)

Interpretation:
Adults and children
Increased total bilirubin that is mainly unconjugated (indirect) bilirubin may be a result of:-

1. Hemolytic or pernicious anemia

2. Transfusion reaction
3. Cirrhosis
4. A relatively common inherited condition called Gilbert syndrome, due to low levels of the enzyme that produces conjugated bilirubin.

Newborns
An elevated bilirubin level in a newborn may be temporary and resolve itself within a few days to two weeks. However, if the bilirubin level is
above a critical threshold or increases rapidly, an investigation of the cause is needed so appropriate treatment can be initiated. Increased
bilirubin concentrations may result from the accelerated breakdown of red blood cells due to:

1. Blood type incompatibility between the mother and her newborn

2. Certain congenital infections
3. Lack of oxygen (hypoxia)
4. Diseases that can affect the liver

In most of these conditions, only unconjugated (indirect) bilirubin is increased.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 6 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : ZF054025
Referred BY : Self Sample Type : Serum
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 07:08 PM.
Test Description Value(s) Unit(s) Reference Range

SGOT / AST

SGOT/AST 26.8 U/L up to 40

IFCC without P5P

Interpretation:
Serum AST is used for differential diagnosis of diseases of hepatobiliary system and pancreas. Increased values are seen in liver diseases
like acute viral hepatitis, cirrhosis, biliary obstruction, primary or metastatic cancer, granuloma, hepatic ischaemia.

SGPT / ALT

SGPT/ALT 30.2 U/L up to 41

IFCC without P5P

Interpretation:
Serum ALT is used for differential diagnosis of diseases of hepatobiliary system and pancreas. Increased in alcohalic hepatitis, cirrhosis,
hepatocellular carcinoma, chronic hepatitis. Decreased in genito-urinary tract infection, malignancy, pyridoxal phosphate deficiency states
(malnutrition, pregnancy, alcoholic liver disease).

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 7 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : ZF054025
Referred BY : Self Sample Type : Serum
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 07:08 PM.
Test Description Value(s) Unit(s) Reference Range

C-Reactive Protein (CRP), Quantitative

CRP (Quantitative) 2.2 mg/L 0-5

Immunoturbidimetric

Interpretation:
Increased CRP level:
1. A high or increasing amount of CRP in the blood suggests the presence of inflammation but will not identify its location or the cause.
2. Suspected bacterial infection—a high CRP level can provide indication that patient has an infection.
3. Chronic inflammatory disease—high levels of CRP suggest a flare-up if you have a chronic inflammatory disease or that treatment has not
been effective.
If the CRP level is initially elevated and drops, it means that the inflammation or infection is subsiding and/or responding to treatment.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 8 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : SI700026
Referred BY : Self Sample Type : Serum
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 07:12 PM.
Test Description Value(s) Unit(s) Reference Range

WIDAL By Slide Agglutination

Salmonella typhi O (TO) No Agglutination Titre < 1:80

Salmonella typhi H (TH) No Agglutination Titre < 1:160
Salmonella paratyphi A(H) No Agglutination Titre < 1:80
Salmonella Paratyphi B(H) No Agglutination Titre < 1:80
Interpretation:

METHOD-(Slide Agglutination)

1.Titres >1:80 of “O” antigen & >1:160 of “H” antigen for Salmonella typhi and titres >1:80 of “H” antigen for Salmonella paratyphi A & B are
reactive.
2. Rising titres in paired samples taken 7-10 days apart are more significant than a single test.
3. Reactive results indicates ongoing or recent infection by Salmonella spp. and the diagnosis should be confirmed by gold standard test such
as Blood culture.
4. The reactivity will vary with stage of the disease with appearance in 1st week to increase in titres till end of 4th week post which it starts
decreasing.
5. In TAB vaccinated patients, high titres of H antibody of ≥1:160 to each of Salmonellae is observed. They tend to persist for many months and
even years while O antibody shows lower titres and disappears within 6 months.
6. Antibiotic treatment during 1st week before the appearance of antibodies tend to supress the immune response in the form of no or
decreasing antibody levels.
7. False positive results/anamnestic response may be seen in patients with past enteric infection and during unrelated fevers like Malaria,
Influenzae etc. in the form of transient rise in H antibody in Widal test.
8. False negative results may be due to processing of sample collected early in the course of disease (1st week) and immunosuppression.
9. Test conducted on serum.

Uses
To diagnose infection due to Salmonella spp. (Enteric fever).
To monitor the progression of disease.
To assess the response to therapy (decreasing titres) in patients being treated for Enteric fever

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 9 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : SI700026
Referred BY : Self Sample Type : Serum
Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 07:12 PM.
Test Description Value(s) Unit(s) Reference Range

Typhidot IgM, Rapid Card

TYPHI DOT/ SALMONELLA TYPHI IgM Negative - Negative

Qualilative immunoassay,rapid card

Interpretation:
RESULTS REMARKS
Positive Indicates presence of IgM antibodies against Salmonella typhi.
Negative Indicates absence of IgM antibodies against Salmonella typhi.

Note:
1.Its positivity in serum indicates ongoing or recent infection by Salmonella typhi and the diagnosis should be confirmed by gold standard test
such as Blood culture prior to start of antibiotics.
2.IgM antibodies are typically detectable 5-7 days post symptom onset, peaking in 2nd week and frequently remain elevated for 2-4 months
following infection.
3.False positive results may be due to cross reactivity with other Salmonella spp., Dengue virus infection & in patients with high levels of
Rheumatoid factor.
4. False negative reaction may be due to processing of sample collected early in the course of disease, antibiotic treatment during 1st week and
immunosuppression.
5. Test conducted on serum.

Use
To diagnose infection due to Salmonella typhi (Enteric fever).

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 10 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : SI700026
Referred BY : Self Sample Type : Serum
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 09:31 PM.
Test Description Value(s) Unit(s) Reference Range

Dengue Ns1 Antigen Test, EIA

DENGUE NS1 ANTIGEN 0.87 OD Ratio. Negative < 1.0

(Serum,EIA) Positive : > 1.0
Interpretation:
BIOLOGICAL REFERANCE INTERVAL
NEGATIVE <1.0
POSITIVE >=1.0

Note: As per regulation, specimen collecting Laboratory is responsible for reporting positive Dengue cases to Municipal corporation.

Indication: The Dengue (NS1) Antigen assay is a Enzyme linked immunoassay (EIA) for the detection of Dengue virus NS1 Antigen in human serum or
plasma(heparin).
The serological detection of the highly specific dengue virus NS1antigen in patients with a dengue virus infection is possible at the onset of clinical symptoms in
primary as well as secondary infections. Thus determination of Dengue (NS1) Antigen is an important supportive aid for diagnosis of acute dengue virus
infections.

Clinical background: Dengue virus (serotypes Den 1, Den 2, Den 3, Den 4) is a flavivirus with global distribution and is transmitted by mosquitoes ( Aedes
aegyptii, Aedes albopictus etc). It may cause Dengue fever, Dengue haemorrhagic fever or Dengue Shock syndrome.
Following the dengue infection, an incubation period of 3 to7 days, some infections maybe asymptomatic. Symptomatic patients develop fever with or without
rash, severe musculoskeletal pain, headache, retro-orbital pain, petechiae etc. In most individuals there is resolution of illness without complications. In some
individuals the Dengue fever may progress to Dengue haemorrhagic fever or Dengue Shock syndrome especially during repeat infection with a new Dengue
Virus serotype.

Dengue virus antigen usually appears in blood within 24 hours of onset of symptoms to symptoms till 9 days post onset of symptoms.

Positive: The presence of Dengue nonstructural protein 1 (NS1) antigen is consistent with acute infection with dengue virus. The NS1 antigen is typically
detectable within 1 to 2 days following infection and up to 9 days following symptom onset. NS1 antigen may also be detectable during secondary dengue virus
infection, but for a shorter duration of time (1-4 days following symptom onset).

Negative: The absence of dengue NS1 antigen is suggestive of absence of acute phase of the infection. The NS1 antigen may be negative if specimen is
collected too early such as immediately following dengue virus infection (<24-48 hours) or is collected following 9 to 10 days of symptoms. Results should always
be interpreted in conjunction with clinical presentation and exposure history.

Limitations: Uncommonly, false positive Dengue NS1 antigen results may be seen in individuals with other flaviviruses west nile virus as well as Yellow fever.
Negative NS1 antigen results may occur if the specimen was collected greater than 7 days following symptom onset. Serologic testing for the presence of IgM
and IgG antibodies to Dengue Virus is recommended in such cases.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 11 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : SI700026
Referred BY : Self Sample Type : Serum
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 09:31 PM.
Test Description Value(s) Unit(s) Reference Range

Dengue IgM Antibodies, EIA

DENGUE FEVER ANTIBODY, IgM, SERUM 0.16 OD Ratio. Negative < 1.0
SERUM, EIA Positive : > 1.0
Interpretation:
RESULT(Units) REMARKS
No detectable IgM antibody. Result does not rule out Dengue infection. Additional
Negative (<1)
sample to be tested after 7-14 days if infection is suspected.
Positive (>=1) IgM antibody detected. Suggestive of Primary / Secondary Dengue infection.

NOTE-
1. The test should be used for detection of IgM antibodies of dengue in human serum/plasma.
2. This is only a screening test and will only indicate the presence or absence of Dengue antibodies in the specimen. All reactive
sample should be confirmed by confirmatory test. Therefore for a definitive diagnosis, the patients clinical history , symptomatology as
well as serological data should be considered. The results should be reported only after complying with the above prrocedure.
3. False positive results can be obtained due to cross reaction with Epstein-BARR virus, RA, Leptospira, Malaria, hepatitis-A, Infuenza
A & B, S.typhi Japanese encephatlites, westnile virus diseased. This occurs in less then 1% of the sample tested.
4. Immuno-despressive treatments presumably after the immune response to infection, inducing negative results in IgM in dengue
patients.

Comments
Dengue viruses belong to the family Flaviviridae and have 4 subtypes (1-4). Dengue virus is transmitted by the mosquito Aedes aegypti
and Aedes albopictus, widely distributed in Tropical and Subtropical areas of the world. Dengue is considered to be the most important
arthropod borne viral disease due to the human morbidity and mortality it causes. The disease may be subclinical, self limiting, febrile
or may progress to a severe form of Dengue hemorrhagic fever or Dengue shock syndrome.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 12 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : SI700026
Referred BY : Self Sample Type : Serum
Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 09:31 PM.
Test Description Value(s) Unit(s) Reference Range

Dengue IgG Antibodies, EIA

DENGUE FEVER ANTIBODY, IgG, SERUM 0.18 OD Ratio. Negative < 1.0
Serum, EIA Positive : > 1.0
Interpretation:
RESULT(Units) REMARKS
No detectable IgG antibody. Result does not rule out Dengue infection. Additional sample to
Negative (<1)
be tested after 7-14 days if infection is suspected.
Positive (>=1) IgG antibody detected. Suggestive of Primary / Secondary Dengue infection.

NOTE-
1. The test should be used for detection of IgG antibodies of dengue in human serum/plasma.
2. This is only a screening test and will only indicate the presence or absence of Dengue antibodies in the specimen. All reactive
sample should be confirmed by confirmatory test. Therefore for a definitive diagnosis, the patients clinical history , symptomatology as
well as serological data should be considered. The results should be reported only after complying with the above prrocedure.
3. False positive results can be obtained due to cross reaction with Epstein-BARR virus, RA, Rubella, Anti-nulcear antibody, Japanese
encephatlites, westnile virus diseased. This occurs in less then 1% of the sample tested.
4. Immuno-despressive treatments presumably after the immune response to infection, inducing negative results in IgG in dengue
patients.

Comments
Dengue viruses belong to the family Flaviviridae and have 4 subtypes (1-4). Dengue virus is transmitted by the mosquito Aedes aegypti
and Aedes albopictus, widely distributed in Tropical and Subtropical areas of the world. Dengue is considered to be the most important
arthropod borne viral disease due to the human morbidity and mortality it causes. The disease may be subclinical, self limiting, febrile
or may progress to a severe form of Dengue hemorrhagic fever or Dengue shock syndrome.

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 13 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : YB339047
Referred BY : Self Sample Type : Spot Urine
....

Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 08:10 PM.
Test Description Value(s) Unit(s) Reference Range

Urine Routine and Microscopic Examination

Physical Examination
Volume * 25 ml -
Colour * Yellow - Pale yellow
Transparency * Clear - Clear
Deposit * Absent - Absent
Chemical Examination
Reaction (pH) 5.0 - 4.5 - 8.0
Double Indicator
Specific Gravity 1.025 - 1.010 - 1.030
Ion Exchange
Urine Glucose (sugar) Negative - Negative
Oxidase / Peroxidase
Urine Protein (Albumin) Negative - Negative
Acid / Base Colour Excahnge
Urine Ketones (Acetone) Negative - Negative
Legals Test
Blood Negative - Negative
Peroxidase Hemoglobin
Leucocyte esterase Negative - Negative
Enzymatic Reaction
Bilirubin Urine Negative - Negative
Coupling Reaction
Nitrite Negative - Negative
Griless Test
Urobilinogen Normal - Normal
Ehrlichs Test
Microscopic Examination
Pus Cells (WBCs) * 1-2 /hpf 0-5
Epithelial Cells * 1-2 /hpf 0-4
Red blood Cells * Absent /hpf Absent
Crystals * Absent - Absent
Cast * Absent - Absent
Yeast Cells * Absent - Absent
Amorphous deposits * Absent - Absent
Bacteria * Absent - Absent
Protozoa * Absent - Absent
Interpretation:
URINALYSIS- Routine urine analysis assists in screening and diagnosis of various metabolic, urological, kidney and liver disorders.

Protein: Elevated proteins can be an early sign of kidney disease. Urinary protein excretion can also be temporarily elevated by strenuous
exercise, orthostatic proteinuria, dehydration, urinary tract infections and acute illness with fever

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 14 of 15
 Patient NAME : Ms Sunita Sharma
DOB/Age/Gender : 40 Y/Female Report STATUS : Final Report
Patient ID / UHID : 10207057/RCL5088382 Barcode NO : YB339047
Referred BY : Self Sample Type : Spot Urine
Sample Collected : Oct 24, 2024, 02:35 PM Report Date : Oct 24, 2024, 08:10 PM.
Test Description Value(s) Unit(s) Reference Range

Glucose: Uncontrolled diabetes mellitus can lead to presence of glucose in urine. Other causes include pregnancy, hormonal disturbances,
liver disease and certain medications.

Ketones: Uncontrolled diabetes mellitus can lead to presence of ketones in urine. Ketones can also be seen in starvation, frequent vomiting,
pregnancy and strenuous exercise.

Blood: Occult blood can occur in urine as intact erythrocytes or haemoglobin, which can occur in various urological, nephrological and bleeding
disorders.

Leukocytes: An increase in leukocytes is an indication of inflammation in urinary tract or kidneys. Most common cause is bacterial urinary tract
infection.

Nitrite: Many bacteria give positive results when their number is high. Nitrite concentration during infection increases with length of time the
urine specimen is retained in bladder prior to collection.

pH: The kidneys play an important role in maintaining acid base balance of the body. Conditions of the body producing acidosis/ alkalosis or
ingestion of certain type of food can affect the pH of urine.

Specific gravity: Specific gravity gives an indication of how concentrated the urine is. Increased specific gravity is seen in conditions like
dehydration, glycosuria and proteinuria while decreased specific gravity is seen in excessive fluid intake, renal failure and diabetes insipidus.

Bilirubin: In certain liver diseases such as biliary obstruction or hepatitis, bilirubin gets excreted in urine.

Urobilinogen: Positive results are seen in liver diseases like hepatitis and cirrhosis and in cases of haemolytic anaemia.

*** End Of Report ***

(*) Parameter(s) are outside the scope of tests recognized under the NABL M(EL)T Scheme.

Booking Centre :- Home Collection

Processing Lab :- Redcliffe Lifetech Pvt. Ltd., F-82, Ground Floor, Patel Nagar City Center, Gwalior-474011

Page 15 of 15
 SMART HEALTH REPORT
RT
MC-5280

About Redcliffe Labs

We are India’s Most Trusted & Fastest Growing Network of Diagnostics Labs
Best Customer 100% Best Prices With
Experience Report Correctness Fast Reports

Commitment to excellence, Focus on quality with Value for money with

high end technology oriented staff accurate results quick turn around time (TAT)

For every 10,000 patients served,

we plant a tree

Select from a wide range of

Full Body Health Check-up
packages that suits your health

Best Selling Package

Annual Health Checkup

Advance Plus with Free HsCRP

Get free report consultation

& download our app

A Simple and easy way to track your health

3600 + Tests & Packages Presence in 220+ Cities

45 Min Express Sample 100% Accurate Report

Collection Guarantee.